Freeline Doses Second Patient of Phase 1/2 MARVEL-1 Clinical Trial for Fabry Disease

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline To Participate In Conferences During January 2022
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021
New England Journal of Medicine Publishes Positive Long-Term Data on Freeline’s Gene Therapy Candidate FLT180a for People with Hemophilia B
Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels